Viridian Therapeutics (VRDN) Earnings Date, Estimates & Call Transcripts $13.62 -0.12 (-0.87%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$14.75 +1.13 (+8.33%) As of 05/2/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viridian Therapeutics Earnings Summary Upcoming Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Feb. 27) -$1.05 Actual EPS (Feb. 27) -$0.81 Beat By $0.24 Actual Revenue (Feb. 27) $0.07MViridian Therapeutics posted Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.81, which topped the consensus estimate of -$1.05 by $0.24. Quarterly revenue was reported to be $0.07 million, above the consensus estimate of $0.05 million. With a trailing EPS of -$3.77, Viridian Therapeutics' earnings are expected to decrease next year, from ($4.03) to ($4.31) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)SEC FilingVRDN Upcoming EarningsViridian Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Viridian Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viridian Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVRDN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRDN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Viridian Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.09-$0.81-$0.97Q2 20254-$1.14-$0.85-$1.01Q3 20254-$1.21-$0.88-$1.04Q4 20254-$1.30-$0.99-$1.13 FY 2025 16 -$4.74 -$3.53 -$4.15 Q1 20261-$1.17-$1.17-$1.17Q2 20261-$1.21-$1.21-$1.21Q3 20261-$1.16-$1.16-$1.16 Viridian Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------2/27/2025Q4 2024-$1.05-$0.81+$0.24-$0.81$0.05M$0.07M11/12/2024--$1.11-$1.15 -$0.04-$1.15$0.08M$0.09M8/8/2024--$0.87-$1.02 -$0.15-$1.02$0.09M$0.07M5/8/2024Q1 2024-$1.07-$0.79+$0.28-$0.79$0.09M$0.07M2/27/2024Q4 2023-$0.98-$1.35 -$0.37-$1.35$0.15M$0.07M11/13/2023Q3 2023-$1.22-$1.09+$0.13-$1.09$0.28M$0.07M8/8/2023Q2 2023-$1.26-$1.27 -$0.01-$1.27$0.25M$0.07M5/9/2023Q1 2023-$1.00-$1.61 -$0.61-$1.61$0.10M$0.10M Viridian Therapeutics Earnings - Frequently Asked Questions When is Viridian Therapeutics's earnings date? Viridian Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on VRDN's earnings history. Did Viridian Therapeutics beat their earnings estimates last quarter? In the previous quarter, Viridian Therapeutics (NASDAQ:VRDN) reported ($0.81) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.05) by $0.24. Learn more on analysts' earnings estimate vs. VRDN's actual earnings. How can I view Viridian Therapeutics's earnings report? Viridian Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Viridian Therapeutics generate each year? Viridian Therapeutics (NASDAQ:VRDN) has a recorded annual revenue of $302,000.00. How much profit does Viridian Therapeutics generate each year? Viridian Therapeutics (NASDAQ:VRDN) has a recorded net income of -$237.73 million. VRDN has generated -$3.77 earnings per share over the last four quarters. What is Viridian Therapeutics's EPS forecast for next year? Viridian Therapeutics's earnings are expected to decrease from ($4.03) per share to ($4.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies RadNet Earnings Sotera Health Earnings GeneDx Earnings BrightSpring Health Services Earnings Privia Health Group Earnings Concentra Group Holdings Parent Earnings Surgery Partners Earnings LifeStance Health Group Earnings Veracyte Earnings Progyny Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:VRDN) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRDN Stock Free VRDN Stock Alerts